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Synopsis
Post-transcriptional gene silencing is a widely used method to suppress gene expression. Unfortunately only a
portion of siRNAs do successfully reduce gene expression. Target mRNA secondary structures and siRNA-mRNA
thermodynamic features are believed to contribute to the silencing activity. However, there is still an open discussion
as to what determines siRNA efficacy. In this retrospective study, we analysed the target accessibility comparing very
high (VH) compared with low (L) efficacy siRNA sequences obtained from the siRecords Database. We determined the
contribution of mRNA target local secondary structures on silencing efficacy. Both the univariable and the multivariable
logistic regression evidenced no relationship between siRNA efficacy and mRNA target secondary structures. Moreover,
none of the thermodynamic and sequence-base parameters taken into consideration (H-b index, G◦overall, G◦duplex,
G◦break-target and GC%) was associated with siRNA efficacy. We found that features believed to be predictive of
silencing efficacy are not confirmed to be so when externally evaluated in a large heterogeneous sample. Although it
was proposed that silencing efficacy could be influenced by local target accessibility we show that this could be not
generalizable because of the diversity of experimental setting that may not be representative of biological systems
especially in view of the many local protein factors, usually not taken into consideration, which could hamper the
silencing process.
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INTRODUCTION
RNAi is an evolutionally conserved sequence-specific, post-
transcriptional gene silencing mechanism first described in Caen-
orhabditis elegans by Mello and Fire [1]. Long dsRNAs are pro-
cessed by Dicer, an RNase type III enzyme and cleaved into
small fragments of 21–23 bps [2–5]. Such cleavage products are
loaded on to the RNA-induced silencing complex (RISC) [6], the
passenger strand of dsRNA is cleaved and discarded whereas
the guide strand is targeted to the complementary mRNA [6] res-
ulting in its degradation [1,7,8]. RNA interfering is a widely used
tool to suppress gene expression but only a portion of siRNAs
are able to reduce gene expression [9,10]. There is still an open
discussion regarding what determines the silencing efficacy of a
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multi-branch loop; mfe, minimum free energies; one-bb, one base bulge; OR, odd ratios; RBP, RNA-binding protein; RISC, RNA-induced silencing complex; VH, very high siRNA efficacy.
1 To whom correspondence should be addressed (email devis.pascut@csf.units.it).
specific siRNA. A role may be played by siRNA sequence fea-
tures [9], siRNA chemical modifications [11], i.e. phosphoryla-
tion, interaction with RNA-binding proteins (RBPs) [12,13] and
mRNA target accessibility. Several reports point out the rel-
evance of targeted secondary structures for silencing efficacy
[14,15]. However, most of the features believed to be relevant
for siRNA efficacy were inferred from restricted experimental
settings, which may misrepresent their contribution [16,17]. The
siRecords database [18] contains more than 17000 records of ex-
perimentally validated mammalian siRNAs obtained from about
6000 independent studies. In the present study, siRNA efficacy
is categorized as very high (VH; 90 %–100 % of silencing effic-
acy), high (H; 70 %–90 %), medium (M; 50 %–70 %) and low (L;
0 %–50 %). In the present retrospective study, we compared 150
VH and 150 L randomly chosen siRNA sequences obtained from
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different experimental settings to evaluate the role of mRNA tar-
geted secondary structures and siRNA-mRNA thermodynamic
features on siRNA efficacy.
MATERIAL AND METHODS
siRNA selection and mRNA secondary structure
targeting
Three-hundred siRNA sequences targeting 267 human genes
were randomly selected from the siRecords database [18].
The 19–21 bp synthetic oligonucleotides were classified as VH
(n = 150) and L (n = 150) on the basis of silencing effic-
acy. The gateway for the siRecords database is http://sirecords.
biolead.org/index.php. From each siRNA, the corresponding
mRNA target sequence was obtained from the NCBI nt database
and folded by using the Mfold web server version 2.3 [19] with
default settings (http://mfold.rna.albany.edu/?q = mfold). Min-
imum free energies (mfe) were predicted. Each siRNA sequence
was manually aligned to the correspondent global mRNA sec-
ondary structure to discriminate the local targeted site among
loop, 5′-loop, 3′-loop, internal loop (int-loop), multi-branch loop
(mb-loop), H-loop, bulge loop (b-loop), one base bulge (one-bb)
and stem structures.
For each siRNA duplex, the number of bases targeting each
mRNA local structure and the number of consecutive unpaired
bases in the target site were identified.
H-b index
To determine the overall probability of nts within the siRNA
targeting region to form double-stranded complex with other parts
of the mRNA, we calculated the H-b index for each pair of siRNA-
mRNA. The H-b index is the average number of hydrogen bonds
formed in all possible mRNA secondary structures as predicted
by the Mfold software. It was proposed by Luo and Chang [20]
as a parameter that takes into account the overall contribution of
mRNA secondary structures in the siRNA binding. Low values
of H-b index indicate that most nts within the target region are
in single-stranded structures and are more likely to be accessible
by the RISC–siRNA complex.
Each mRNA sequence was previously folded by MFold web
server version 2.3 [19] using default settings. The ss-count output
was taken into account in order to calculate the H-b index for the
siRNA targeted region. The ss-count is the propensity of a base to
be single-stranded, as measured by the number of times it happens
to be single-stranded in a group of predicted RNA structures. The
H-b index was calculated for the two groups of siRNAs according
to Luo and Chang [20].
Binding affinity
The Oligowalk program [21] included in the software package
RNAstructure version 5.3 [22] was used to predict the binding
affinity of each oligonucleotide to its mRNA target. In particular,
three parameters were taken into account:
G◦overall: The net G in kcal/mol (1 cal≡4.184 J) of oligo-
target binding, when all contributions are considered, including
breaking target structure and oligo-self-structure, if any. A more
negative value indicates tighter binding.
G◦duplex: The free energy change due to hybridization at the
binding site. It measures the oligo-target binding affinity from
unstructured states. A more negative value indicates more stable
duplex.
G◦break-target: The free energy cost for opening bps in the
region of complementarity to the target so that the binding site
becomes completely open. A more negative value indicates less
accessible siRNA.
GC content analysis
The siRNA were separated into siRNA with GC content <25 %,
between 25 % and 55 % and >55 %. We also evaluated subgroups
with GC content from 25 % to 34 %, 35 % to 44 %, 45 % to 54 %
and 55 to 64 %.
Statistical analysis
The separate contribution of loop 5′-loop 3′-int-loop, mb-loop, h-
loop, b-loop, one-bb and stem to siRNA efficacy was evaluated by
univariable logistic regression. Multivariable logistic regression
was used to quantify the joint contribution of the same predictors
to siRNA efficacy. siRNA efficacy was coded as 0 = low and
1 = very high and all predictors were modelled as continuous
(number of occurrences).
Univariable logistic regression was used to evaluate the con-
tribution of consecutive unpaired bases on the RNA target to
the siRNA efficacy. Odd ratios (OR) and robust 95 % confidence
intervals (CI) were calculated as measures of effect size.
Between-group comparisons were performed with Student’s
unpaired ttest for Gaussian distributions and with Mann–Whitney
U-test for non-Gaussian distribution.
Fisher’s exact test was used to estimate the probability of get-
ting the observed data under the assumption that the frequencies
of VH and L siRNA with GC content 25 %–55 % are the same.
Pearson’s chi-square test was used to estimate the probability
of getting the observed data under the null hypothesis that the
proportions of VH and L siRNA within the GC content subgroups
are the same.
RESULTS AND DISCUSSION
siRNA efficacy and local secondary structures
The efficacy of siRNA on gene silencing varies within targeting
sites of the same mRNA [5,10,23–25]. There is still an open dis-
cussion as to what determines those silencing efficacy. Although
it was proposed that silencing efficacy could be influenced only by
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Figure 1 mRNA target secondary structures analysis
(a) For each siRNA, information on the targeted region within the mRNA was collected. (b) The number and position of
unpaired bases within the mRNA local targeted region were listed. A single siRNA can target several local structures.
siRNA intrinsic characteristics [9]; previous studies have shown
that local target accessibility might contribute to silencing effic-
acy [14,26]. However, these studies may not be generalizable be-
cause they involved low numbers of siRNAs and target structures.
The contribution of target accessibility in a given experimental
setting may not to be representative of biological systems, espe-
cially in view of the many local factors, such as RBPs, chaperons,
RNA–RNA interactions, metabolites and ions that have effect on
the RNA folding in vivo [12,13,27]. In this retrospective study,
we analysed the target accessibility and the thermodynamic prop-
erties of a large number of siRNA with particular attention to the
portion of siRNA targeting a given local secondary structure on
the mRNA.
We evaluated 300 randomly chosen siRNA sequences and
their targets from siRecords Database. To reduce bias, no more
than two siRNAs per working group were selected in each
category.
Each mRNA was folded using the Mfold web server version
2.3 [19] and in each siRNA targeted region were identified both
the local structures and the number of unpaired bases within the
mRNA (see Figure 1 for an example).
Schubert et al. [14] observed that silencing is greatly influ-
enced by the number of paired nts within the mRNA target. These
nts are likely to be incorporated in hairpin structures which are
unfavourable for siRNA silencing [14,28].
To determine whether silencing efficacy depends on the num-
ber of unpaired bases within the mRNA targeted region, we eval-
uated the frequency of siRNAs targeting mRNA sites with the
predicted number of base-pairing (Figure 2). Logistic regres-
sion was used to evaluate the association between the number
of unpaired bases within the mRNA target region and siRNA
efficacy. Although most L siRNAs are reported to preferentially
target mRNA regions with a low number of unpaired bases (4–
8) our analysis showed no association between the number of
unpaired bases in the mRNA target region and the siRNA effic-
acy (OR = 1.00; 95 % CI, 0.89–1.12; P = 1.0). We also found no
association between the number of consecutive unpaired nts per
targeted local mRNA secondary structure (OR = 1.03, 95 % CI,
0.97–1.09 P = 0.269; Figure 3). Thus, we were not able to rep-
licate Schubert’s findings on an external and much larger dataset.
The position of unpaired nts within the target was taken into
account to test whether the mRNA has a role in determining
siRNA efficacy. Table 1 summarizes the distribution of unpaired
bases within the siRNA targeted structures. It should be noted that
a single siRNA can target one, two or more secondary mRNA
structures.
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Figure 2 Number of unpaired bases per local mRNA targeted structure
Figure 3 Number of consecutive unpaired bases within the targeted mRNA local structure
Since it has been reported that targeting loop-based structures
has a positive influence on silencing efficacy [15,20], an associ-
ation between silencing efficacy and local targeted mRNA struc-
tures was expected. However, we found no association between
silencing efficacy and targeted mRNA local structure (Table 2).
Loop-based structures have been reported to be more favourable
for highly effective siRNA binding [15], but we found again that
they were not predictive of silencing efficacy (Table 2).
Although mRNA secondary structures could influence siRNA
binding, they cannot be considered the only factor determining
silencing efficacy. Indeed, Holen et al. [10] reported variable si-
lencing efficacies in siRNAs targeting similar predicted second-
ary structures. Gredell et al. [15] noticed that siRNA silencing
efficacy may depend on the transfected cell line independently of
the mRNA local region targeted. Furthermore, whereas Overhoff
et al. [26] found an improvement in siRNA efficacy based on
target accessibility, they also noted that not all siRNAs against
inaccessible targets are ineffective. Finally Amarzguioui et al.
[29] encountered some discrepancies between silencing experi-
ments conducted in vitro and in vivo. Putting these observations
together with our findings, it appears that the target secondary
structure has not a clear role in siRNA silencing efficacy. Other
factors, rarely taken into consideration, for instance RBPs, may
also influence siRNA binding and silencing efficacy [13]. In vivo
RNA is not a ‘naked’ molecule, but is bound to a dynamic set
of RBPs that begin to be deposited on to the RNA molecule
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 c© 2015 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/)
which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Silencing efficacy prediction: a retrospective study on target mRNA features
Table 1 Distribution of unpaired bases within the siRNA targeted structures
Loop 5′ Loop 3′ Int-loop mb-Loop H-loop b-Loop One-bb Stem
Unpaired bases VH L VH L VH L VH L VH L VH L VH L VH L
Number of observations (siRNAs)
0 94 91 102 111 82 88 83 95 114 118 127 135 99 106 90 89
1 7 18 2 10 1 – 22 18 – – 1 – 38 41 28 33
2 8 13 10 10 21 17 15 17 – – 7 3 5 2 15 19
3 8 10 13 5 13 11 9 5 3 6 5 3 – – 6 2
4 5 5 6 7 7 9 6 4 4 6 2 4 – – 4 5
5 8 4 4 2 6 10 2 4 13 12 1 2 – – – –
6 5 – 1 – 4 5 1 1 22 2 – 1 – – – 1
7 – – – – – – – – 3 3 – – – – – –
8 – – – – – – – – 2 – – – – – – –
9 – – – – – – – – – – – – – – – –
10 – 1 1 1 – 2 – – – – – – – – – –
11 – 2 – – – 1 – – – – – – – – – –
12 – – – – – – 1 – – – – – – – – –
13 1 – – – 1 – – – – – – – – – – –
14 1 – 1 – – – – – 1 – – – – – – –
15 – – – – – – – – – – – – – – – –
16 – – – – – – – – – – – – – – – –
17 – – 1 – – – – – – – – – – – – –
18 – – – 1 – – – – – – – – – – – –
The table reports the number of observations (siRNAs) targeting mRNA regions with a variable number of unpaired bases. A single siRNA can target more than one local secondary
structure within the mRNA. Only few siRNAs (both VH and L) bind to mRNA regions with higher amounts of unpaired nts.
co-transcriptionally [12]. Thus RBPs not only affects the RNA
secondary structure but also can occasionally mask siRNA target
sites. The implication is that RBPs could influence siRNA effic-
acy [13]. The full complement of proteins associated in vivo is
likely to be different from that bound to the same RNA in vitro.
Frequently in vitro experiments are not able to reproduce such a
complex system producing biased results and a lack of correlation
between in vitro accessibility and in vivo efficacy [13,29].
H-b index
One important issue to be considered is the RNA secondary
structure prediction. Although there are some evidences about
the accuracy of the computational methods [15,26], it is worth to
notice that the secondary-structure predictions based on the mfe
calculation, used by Mfold, assume that the total free energy is
the sum of independent contributions by the singles paired or un-
paired nts within the RNA sequence. These contributions could
be sensitive to small changes in the energy parameters, temperat-
ure, ions concentrations. Not necessarily the thermodynamically
most stable structure is the one encountered in vivo [12]. Tak-
ing into consideration these evidences, we used the H-b index
to predict target accessibility [20]. This index takes into account
all possible secondary structures of a given RNA to estimate the
probability that a base within the RNA sequence is in a single- or
double-stranded conformation. If the target region of the mRNA
has a more loosened structure (i.e., less intramolecular hydrogen
bonding) as in the case of loop-based structures, it should be
easier for the siRNA to bind with the targeted mRNA through
base-pairing. Thus, the H-b index provides a measure of mRNA
accessibility.
Luo and Chang [20] found that low H-b indexes (<25) were
predictive of high silencing efficacy. However, they considered a
low number of siRNAs and mRNA targets and their data were
obtained from a single-group study targeting a single mRNA. In
the present study, we found that the mean (S.D.) H-b index was
nearly the same for VH compared with L siRNA (31.29 +− 6.97
and 31.82 +− 5.29 respectively, P = 0.82). Using a cut-point of
25 for the siRNA index, was again found no association with
silencing efficacy (95%CI, 0.88–1.9, P = 0.085).
Binding affinity
Several groups recommend considering thermodynamic prop-
erties when performing siRNA studies [21,30]. In the present
work, we used Oligowalk v3.5 [21] to analyse the thermody-
namic properties of siRNAs. In detail, we evaluated overall G◦,
i.e. the overall Gibbs free energy change of RNA binding at 37 ◦C.
This parameter takes into account the G◦ variation of break-
ing target structures and of intramolecular secondary structural
formation, including self-structure formation in the target and
in the siRNA. Since the silencing efficacy should be positively
associated with the stability of the siRNA-mRNA duplex and
negatively associated with the stability of the siRNA and mRNA
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) secondary structure, the overall G◦ should be associated with
siRNA efficacy. However, we found that overall G◦ was similar
in VH compared with L siRNA [mean (S.D.) − 19.18 +− 7.37 and
− 18.26 +− 7.09 respectively; P = 0.27]. It appears therefore that
G◦overall is not associated with siRNA efficacy although some
reports have shown a weak association [30]. Similar results were
obtained when considering the G◦break-target that corresponds to
the free energy cost for breaking the target intramolecular bps at
the binding site that becomes completely single stranded. More
negative values mean that the binding site is less accessible for
siRNA binding.
In a sample of about 100 siRNAs challenged against three
human genes, Shao et al. [31] found that G◦break-target was
the only predictor of siRNA efficacy. In the present study,
based on 300 siRNAs targeting 267 different mRNAs, we find
similar G◦break-target values for VH compared with L siRNAs
[mean (S.D.) − 14.56 +− 8.52 compared with − 14.58 +− 7.04;
P = 0.99].
We also evaluated the stability of the potential siRNA-mRNA
duplex (G◦Mduplex). In theory, the more stable is the duplex,
the more negative is the G◦duplex value. Although we found a
statistically significant difference in G◦duplex between VH and L
siRNA, ( − 35.57 +− 4.73 and for L − 33.11 +− 10.82; P = 0.04),
this difference is unlikely to be biologically relevant. A poor
predictive ability for G◦duplex was reported also from Shao et
al. [31]. An association between G◦duplex and siRNA efficacy
was reported by Matveeva et al. [30] at a cut-off − 30 kcal/mol.
However, use of such cut-off offered no improvement in the
present study as the percentage of L siRNA with G◦duplex 
− 30 kcal/mol was actually greater than VH siRNAs (14.7 %
compared with 8.7 %; P = 0.09).
GC content and siRNA efficacy
Some studies have shown that a low GC content (30 %–55 %)
has a positive effect on silencing [32–34] whereas other studies
have shown only a weak association [35,36]. CG content surely
influences both RISC loading and target affinity and specificity.
A higher CG content may negatively influence the dissociation
of the siRNA duplex hampering RISC loading [37,38]. On the
other side, it has been postulated that a low GC percentage may
decrease silencing by reducing target affinity [39]. In a previ-
ous study [40] where several CG content ranges were analysed,
51.7 % of effective siRNA (product level less than 30 %) had a GC
content of 25 %–55 %. When shifting this range toward higher GC
contents (35 %–75 %) the percentage of effective siRNAs reduced
up to 42.2 %. In our analysis we considered also the threshold
25 %–55 % and we did not find any statistically significant dif-
ference between VH and L siRNA (86 % compared with 79 %;
P = 0.2) indicating that this CG range is not a discriminating
factor for VH and L siRNAs. To support these results, we tested
the null hypothesis that the 51.7 % of VH siRNA have a GC
content 25 %–55 % obtaining a statistically significant difference
between observed and expected frequencies (P = 0.001). When
considering different subgroups (25 %–34 %; 35 %–44 %; 45 %–
54 %; 55 %–64 %) again we did not find any statistically relevant
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difference among VH and L siRNAs (8 % compared with 12 %;
36 % compared with 28 %; 46.7 % compared with 43 %, 14 %
compared with 14 %; P = 0.85). Although GC% affects the ther-
modynamic stability of siRNA duplex and target binding, at least
in vitro and in silico, it is not central for silencing efficacy in vivo
and this is in agreement with the findings of Tafer et al. [41] who
consider the GC content a poor predictor of siRNA efficacy.
CONCLUSION
The evidence that siRNAs synthesized against a common RNA
target have different silencing efficacies has pointed out the im-
portance of secondary structures on silencing activities. Stud-
ies have shown that a relationship between siRNA efficacy and
mRNA target secondary structure exists [15,26]; however, a com-
mon drawback of these studies is the so-called ‘over-fitting prob-
lem’ [16,17]. In other words, the siRNA-mRNA target features
involved in siRNA efficacy extracted from data that have small
sample size and unique experimental settings (i.e. a set of siRNA
against the same target or a restrict number of targets) are likely
to perform unsatisfactorily when applied on large datasets un-
der different experimental settings. In vitro experiments could
not accurately represent the dynamic setting encountered in vivo.
This is due to the presence of RBPs, chaperons, RNA–RNA in-
teractions, metabolites and ions that affect the RNA folding [12].
In addition, differences in the expression and turnover of sev-
eral components of the RISC pathways were observed among
cell lines and tissues [27,42]. Another aspect influencing the de-
gree to which a target gene is silenced in vitro is represented
by the target protein stability and turnover. It is accepted that
many proteins have different cellular stabilities depending on
their biological functions. Poor correlation between mRNA and
protein, as expected for transcription factors, cell-cycle modulat-
ors and signalling transducers, could provide a biased evaluation
of siRNA efficacy [43].
In the present study, we analysed several siRNA-mRNA tar-
get features involved in silencing efficacy, most of them derived
from a unique experimental setting. We found out that features
believed to be predictive of silencing efficacy are not such when
transferred to a larger dataset of experiments and different experi-
mental settings. In particular, from our analysis we cannot derive
any preference for VH and L siRNAs in targeting a particular
mRNA local structure. Moreover none of the considered thermo-
dynamic and sequence-base parameters (i.e. G◦overall, G◦duplex,
G◦break-target and GC%) is predictive for siRNA efficacy. We
believe that although secondary structures and thermodynamic
parameters are important for siRNA efficiency, they are not suffi-
cient to reliably predict siRNA efficacy [44], many other factors
could hamper the silencing process in vivo preventing mRNA
target recognition and binding [12,13]. Usually not taken into
consideration this aspect could be relevant since, for instance,
mRNA interacting proteins are not the same for all RNAs and
they change depending on the RNA processing stage [45]. Thus
the question as to which factors determine siRNA silencing ef-
ficacy is still open and should be reconsidered in view of these
observations.
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